Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1983 Sep-Dec;56(5-6):475–479.

Immunologic mechanisms suggested in the association of M. pneumoniae infection and extrapulmonary disease: a review.

G W Fernald
PMCID: PMC2590510  PMID: 6433568

Abstract

Numerous case reports and retrospective studies suggest an association between M. pneumoniae respiratory infection and extrapulmonary complications, the most common of which involve the central nervous system. There is insufficient evidence based on prospective, carefully controlled observations to confirm this association at the present time. A variety of mechanisms has been suggested to explain the involvement of distant organ systems. These include metastatic infection, autoimmunity, toxin generation, and altered host immunity. While none of these is based on evidence to prove an association, the state of anergy which accompanies M. pneumoniae pneumonia deserves consideration and further study as the most plausible link between infecting organisms and extrapulmonary manifestations.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer A. S., Galpin J. E., Theofilopoulos A. N., Guze L. B. Neurological disease associated with Mycoplasma pneumoniae pneumonitis: demonstration of viable Mycoplasma pneumoniae in cerebrospinal fluid and blood by radioisotopic and immunofluorescent tissue culture techniques. Ann Intern Med. 1981 Jan;94(1):15–20. doi: 10.7326/0003-4819-94-1-15. [DOI] [PubMed] [Google Scholar]
  2. Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol. 1971 Feb;8(2):319–333. [PMC free article] [PubMed] [Google Scholar]
  3. Biberfeld G., Norberg R. Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol. 1974 Jan;112(1):413–415. [PubMed] [Google Scholar]
  4. Biberfeld G., Sterner G. Effect of Mycoplasma pheumoniae infection on cell-mediated immunity. Infection. 1976;4(1 Suppl):17–20. doi: 10.1007/BF01638416. [DOI] [PubMed] [Google Scholar]
  5. Collier A. M., Clyde W. A. Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium. Infect Immun. 1971 May;3(5):694–701. doi: 10.1128/iai.3.5.694-701.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fleischhauer P., Hüben U., Mertens H., Sethi K. K., Thürmann D. Nachweis von Mycoplasma pneumoniae im Liquor bei akuter Polyneuritis. Dtsch Med Wochenschr. 1972 Apr 28;97(17):678–682. doi: 10.1055/s-0028-1107421. [DOI] [PubMed] [Google Scholar]
  7. Foy H. M., Kenny G. E., McMahan R., Mansy A. M., Grayston J. T. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA. 1970 Nov 30;214(9):1666–1672. [PubMed] [Google Scholar]
  8. Hodges G. R., Fass R. J., Saslaw S. Central nervous system disease associated with Mycoplasma pneumoniae infection. Arch Intern Med. 1972 Aug;130(2):277–282. [PubMed] [Google Scholar]
  9. Lerer R. J., Kalavsky S. M. Central nervous system disease associated with Mycoplasma pneumoniae infection: report of five cases and review of the literature. Pediatrics. 1973 Nov;52(5):658–668. [PubMed] [Google Scholar]
  10. Lind K., Zoffmann H., Larsen S. O., Jessen O. Mycoplasma pneumoniae infection associated with affection of the central nervous system. Acta Med Scand. 1979;205(4):325–332. doi: 10.1111/j.0954-6820.1979.tb06057.x. [DOI] [PubMed] [Google Scholar]
  11. Michel D., Laurent B., Granouillet R., Gaudin-Terrasse O. D. Infections aiguës, récentes, et parfois persistantes à Mycoplasma pneumoniae, associées à des manifestations neurologiques. Discussion des liens de causalité. Rev Neurol (Paris) 1981;137(6-7):393–413. [PubMed] [Google Scholar]
  12. Naftalin J. M., Wellisch G., Kahana Z., Diengott D. Letter: Mycoplasma pneumoniae septicemia. JAMA. 1974 Apr 29;228(5):565–565. doi: 10.1001/jama.228.5.565d. [DOI] [PubMed] [Google Scholar]
  13. Pönkä A. The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations. Ann Clin Res. 1979;11 (Suppl 24):1–60. [PubMed] [Google Scholar]
  14. Sabato A. R., Cooper D. M., Thong Y. H. Transitory depression of immune function following Mycoplasma pneumoniae infection in children. Pediatr Res. 1981 May;15(5):813–816. [PubMed] [Google Scholar]
  15. Taylor G., Taylor-Robinson D., Fernald G. W. Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. J Med Microbiol. 1974 Aug;7(3):343–348. doi: 10.1099/00222615-7-3-343. [DOI] [PubMed] [Google Scholar]
  16. Tully J. G. Mycoplasmal toxins. Isr J Med Sci. 1981 Jul;17(7):604–607. [PubMed] [Google Scholar]
  17. YESNICK L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med. 1956 Jan;97(1):93–98. doi: 10.1001/archinte.1956.00250190109010. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES